endocannabinoid

Evidences for the Anti-panic Actions of Cannabidiol

ABSTRACT Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population. Currently, long-term selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for PD; however, the common side-effect profiles and drug interactions may provoke patients to abandon the treatment, leading to PD symptoms relapse. Cannabidiol (CBD) is the major …

Evidences for the Anti-panic Actions of Cannabidiol Read More »

Scroll to Top
Scroll to Top